Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-23-038409

Director acquired 249 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Molineaux Christopher P. Director 2023-06-15 Option exercise +51 $0.72 $37 31,805 D
Molineaux Christopher P. Director 2023-06-15 Option exercise +198 $1.52 $301 32,003 D
Derivatives
Molineaux Christopher P. Director 2023-06-15 Option exercise · Stock Option (right to buy) −51 0 D
Molineaux Christopher P. Director 2023-06-15 Option exercise · Stock Option (right to buy) −198 0 D
Loading xslF345X04/doc4.xml…